Page last updated: 2024-11-05

8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine and Angiogenesis, Pathologic

8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine has been researched along with Angiogenesis, Pathologic in 1 studies

8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine: adenosine receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mino, RP1
Spoerri, PE1
Caballero, S1
Player, D1
Belardinelli, L1
Biaggioni, I1
Grant, MB1

Other Studies

1 other study available for 8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine and Angiogenesis, Pathologic

ArticleYear
Adenosine receptor antagonists and retinal neovascularization in vivo.
    Investigative ophthalmology & visual science, 2001, Volume: 42, Issue:13

    Topics: Angiography; Animals; Animals, Newborn; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Pu

2001